Status: Phase 2
Entry Type: Small molecule
Molecule Category: UNKNOWN

Indications

Mesh Heading Maximum Phase Reference
Endometrial Neoplasms Phase 2 ClinicalTrials
Endometrial Neoplasms Phase 2 ClinicalTrials
Leukemia; Myelodysplastic Syndromes; Preleukemia Phase 1/Phase 2 ClinicalTrials
Multiple Myeloma; Neoplasms, Plasma Cell Phase 1/Phase 2 ClinicalTrials
Glioblastoma; Triple Negative Breast Neoplasms Phase 1/Phase 2 ClinicalTrials
Multiple Myeloma; Neoplasms, Plasma Cell Phase 1/Phase 2 ClinicalTrials
Neoplasms; Neuroendocrine Tumors Phase 2 ClinicalTrials
Glioma Phase 1 ClinicalTrials
Leukemia; Leukemia, Myeloid; Leukemia, Myeloid, Acute; Myelodysplastic Syndromes; Preleukemia; Syndrome Phase 1 ClinicalTrials
Glioblastoma; Glioma Phase 2 ClinicalTrials
Breast Neoplasms; Endometrial Neoplasms; Triple Negative Breast Neoplasms Phase 2 ClinicalTrials
Glioma Phase 2 ClinicalTrials
CONTENTS